Piramal Pharma Limited (PPLPHARMA) Stock - Complete Technical Analysis - Sep 19, 2024

Piramal Pharma Stock Analysis Key Support & Resistance Levels September 2024

Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and it's essential to conduct thorough research or consult with a financial advisor before making investment decisions. Piramal Pharma Limited (PPLPHARMA) is trading at 224, which is 8.25% below its 52-week high of 243.99 and 155.85% above its 52-week low of 87.5.

The technical indicators present a generally bullish outlook. The RSI is in the upper range, indicating strong momentum, while the Stochastic %K suggests the stock may be in an overbought condition. The Stochastic RSI is pointing to a potential consolidation phase. The MACD is showing a positive trend, supporting the bullish sentiment. The Awesome Oscillator also confirms this with a positive reading.

Support levels are observed around 220 and 210, while resistance is seen near 230 and 240. The high ADX reading indicates a strong trend, suggesting that the current bullish momentum might continue. The Momentum indicator reflects positive movement, reinforcing the bullish view. The Commodity Channel Index and Williams Percent Range indicate some strength but also highlight potential for pullbacks.

The recent technical patterns and high ATR values suggest that traders should be prepared for possible volatility. The Ichimoku Base Line and moving averages further suggest that the stock is maintaining an upward trend, with potential for price fluctuations as it approaches resistance levels.

Traders should keep an eye on the support and resistance zones and monitor the broader trend indicated by the ADX and MACD. The volatility highlighted by the ATR indicates that price swings could be significant, so stay alert to market movements.